ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Denis Chem Lab Limited shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director. His three-year term is effective from August 1, 2026.
Denis Chem Lab Limited's shareholders confirmed the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors. The appointment is for a five-year term ending FY 2030-31.
Denis Chem Lab Limited conducted its 45th Annual General Meeting on September 25, 2026. Key businesses transacted included the declaration of a Rs. 2.50 per share dividend and management re-appointments.
VS Holding BV sold 307,594 shares in Denis Chem Lab Ltd, reducing its stake to 16.46%. This disclosure was filed under SEBI SAST regulations.
Denis Chem Lab Limited has issued a notice for its 45th Annual General Meeting scheduled for September 25, 2026. The agenda includes dividend declaration and reappointment of directors.
Denis Chem Lab Limited submitted its Annual Report for FY 2025-26 along with the notice for its 45th Annual General Meeting.
Denis Chem Lab Ltd reported revenue from operations of ₹44 Cr (+1.6% YoY) and net profit of ₹2 Cr (-20.0% YoY) for Q1 FY27.
Denis Chem Lab Limited has scheduled a board meeting on August 13, 2026. The board will consider and approve unaudited financial results for the June 2026 quarter.
VS Holding BV sold a 2.06% stake in Denis Chem Lab Limited through open market transactions. The seller's holding decreased from 20.74% to 18.68%.
Denis Chem Lab recommended a final dividend of ₹2.50 per equity share for FY2025-26. The dividend is subject to shareholder approval at the AGM.
Denis Chem Lab Ltd has reappointed Dr. Himanshu C. Patel as Managing Director for three years. The appointment is effective from August 1, 2026.
Denis Chem Lab Ltd scheduled its 45th AGM for September 25, 2026. The company also fixed a record date for dividend entitlement on September 18, 2026.
Denis Chem Lab Ltd reported revenue from operations of ₹46.8 Cr (+13.0% YoY) and net profit of ₹0.4 Cr (-42.9% YoY) for Q4 FY26.
Denis Chem Lab approved FY26 audited financial results and recommended a Rs. 2.50 per share dividend. New Secretarial and Cost Auditors were also appointed.
Denis Chem Lab Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The report confirms compliance with SEBI regulations and statutory provisions during the period.
Denis Chem Lab Limited scheduled a board meeting for May 30, 2026. Directors will consider FY2025-26 audited financial results and potential dividend recommendations.
Denis Chem Lab Limited announced the resignation of its Secretarial Auditors, M/s. Nishant Pandya & Associates, effective May 6, 2026. The resignation is attributed to personal reasons and applies from the Financial Year 2025-26 onwards. The company confirmed there are no other material reasons for the departure.
Denis Chem Lab Limited announced the resignation of its Secretarial Auditors, M/s. Nishant Pandya & Associates, effective from May 6, 2026. The resignation is attributed to personal reasons and applies from the Financial Year 2025-26 onwards. The company has provided the necessary disclosures under Regulation 30 of the Listing Regulations.
Denis Chem Lab Ltd clarified to BSE that recent share price movements are purely market-driven. The company confirmed all material information has been disclosed per SEBI Regulation 30 and no pending announcements exist. This response addresses the exchange's inquiry dated April 9, 2026, regarding price volatility.
Denis Chem Lab Ltd reported net profit of ₹3.3 Cr (+83.3% YoY) for Q3 FY26.
Denis Chem Lab Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI DP Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed the processing of dematerialisation requests within prescribed timelines.